Some experimental studies conducted on rat and primate eyes have shown that intravitreal anti-VEGF treatment generates geographic atrophy as a result of the reduced fenestration of the choriocapillaris during treatment [97]. The gene discussed is VEGFA; the disease is atrophic macular degeneration.